Compare Sun Pharma with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs FDC LTD. - Comparison Results

SUN PHARMA     Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA FDC LTD. SUN PHARMA/
FDC LTD.
 
P/E (TTM) x 28.3 18.5 153.2% View Chart
P/BV x 2.9 3.6 80.1% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 SUN PHARMA   FDC LTD.
EQUITY SHARE DATA
    SUN PHARMA
Mar-19
FDC LTD.
Mar-18
SUN PHARMA/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs679319 212.8%   
Low Rs375164 228.9%   
Sales per share (Unadj.) Rs121.161.6 196.5%  
Earnings per share (Unadj.) Rs13.49.9 134.4%  
Cash flow per share (Unadj.) Rs20.712.0 172.9%  
Dividends per share (Unadj.) Rs2.750-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs172.673.2 235.9%  
Shares outstanding (eoy) m2,399.26174.40 1,375.7%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.43.9 111.1%   
Avg P/E ratio x39.424.3 162.3%  
P/CF ratio (eoy) x25.520.2 126.2%  
Price / Book Value ratio x3.13.3 92.5%  
Dividend payout %20.60-   
Avg Mkt Cap Rs m1,264,65042,118 3,002.7%   
No. of employees `00017.55.5 316.4%   
Total wages/salary Rs m59,6712,167 2,754.0%   
Avg. sales/employee Rs Th16,608.11,943.7 854.5%   
Avg. wages/employee Rs Th3,409.6391.7 870.4%   
Avg. net profit/employee Rs Th1,833.8313.7 584.6%   
INCOME DATA
Net Sales Rs m290,65910,751 2,703.6%  
Other income Rs m10,255510 2,012.3%   
Total revenues Rs m300,91411,260 2,672.3%   
Gross profit Rs m63,0762,267 2,782.5%  
Depreciation Rs m17,533351 4,989.3%   
Interest Rs m5,55314 39,660.7%   
Profit before tax Rs m50,2462,411 2,083.9%   
Minority Interest Rs m0-5 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-12,1440-   
Tax Rs m6,009671 895.2%   
Profit after tax Rs m32,0931,735 1,849.6%  
Gross profit margin %21.721.1 102.9%  
Effective tax rate %12.027.8 43.0%   
Net profit margin %11.016.1 68.4%  
BALANCE SHEET DATA
Current assets Rs m310,6927,213 4,307.7%   
Current liabilities Rs m173,3962,104 8,242.4%   
Net working cap to sales %47.247.5 99.4%  
Current ratio x1.83.4 52.3%  
Inventory Days Days9954 181.7%  
Debtors Days Days11228 402.4%  
Net fixed assets Rs m232,4776,865 3,386.5%   
Share capital Rs m2,399175 1,369.5%   
"Free" reserves Rs m411,69112,586 3,271.0%   
Net worth Rs m414,09112,761 3,244.9%   
Long term debt Rs m15,2266 253,768.3%   
Total assets Rs m646,93815,041 4,301.1%  
Interest coverage x10.0173.2 5.8%   
Debt to equity ratio x00 7,820.4%  
Sales to assets ratio x0.40.7 62.9%   
Return on assets %5.811.6 50.0%  
Return on equity %7.813.6 57.0%  
Return on capital %10.219.0 53.6%  
Exports to sales %012.3 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA1,327 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m66,0251,889 3,495.6%   
Fx outflow Rs m38,6100-   
Net fx Rs m27,4151,889 1,451.4%   
CASH FLOW
From Operations Rs m21,9651,498 1,465.9%  
From Investments Rs m-6,813201 -3,387.6%  
From Financial Activity Rs m-27,305-1,694 1,611.6%  
Net Cashflow Rs m-8,44210 -81,956.3%  

Share Holding

Indian Promoters % 63.7 68.9 92.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.1 4.7 109.1%  
FIIs % 23.0 7.5 306.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 8.3 19.0 43.7%  
Shareholders   133,026 23,730 560.6%  
Pledged promoter(s) holding % 0.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   CIPLA  PIRAMAL ENTERPRISES  NATCO PHARMA  SHASUN PHARMA  PFIZER  

Compare SUN PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Tanks 661 Points; Banking and Finance Stocks Witness Huge Selling(Closing)

Indian share markets fell sharply today, led by weak Asian equities as worries of new lockdowns to stem surging coronavirus cases kept investors cautious worldwide.

Related Views on News

BIOCON Share Price Up by 5%; BSE HEALTHCARE Index Down 0.2% (Market Updates)

Jul 14, 2020 | Updated on Jul 14, 2020

BIOCON share price is trading up by 5% and its current market price is Rs 436. The BSE HEALTHCARE is down by 0.2%. The top gainers in the BSE HEALTHCARE Index are BIOCON (up 5.1%) and FDC LTD. (up 5.1%). The top losers are J.B.CHEMICALS (down 0.2%) and SANOFI INDIA (down 0.2%).

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

FDC LTD. Announces Quarterly Results (3QFY20); Net Profit Up 67.7% (Quarterly Result Update)

Feb 10, 2020 | Updated on Feb 10, 2020

For the quarter ended December 2019, FDC LTD. has posted a net profit of Rs 733 m (up 67.7% YoY). Sales on the other hand came in at Rs 3 bn (up 26.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, SUN PHARMA has posted a net profit of Rs 10 bn (down 29.8% YoY). Sales on the other hand came in at Rs 82 bn (up 5.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

FDC LTD. Announces Quarterly Results (2QFY20); Net Profit Up 45.4% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, FDC LTD. has posted a net profit of Rs 627 m (up 45.4% YoY). Sales on the other hand came in at Rs 3 bn (up 28.8% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

These 3 Recent Events Will Impact the Price of Gold(Fast Profits Daily)

Jul 1, 2020

Recent developments in the bullion market may put some short term pressure on gold prices.

Smallcaps Are in a Sweet Spot Again: Are You Buying?(Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Jul 14, 2020 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA - DR. DATSONS LABS COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS